INFECTIONS IN NEUTROPENIC PATIENTS .2. MANAGEMENT

Improvement in supportive care including the introduction of new antib iotics, antiviral and antifungal agents and haematopoietic growth fact ors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infection during neutropen ia is still a major complication and a great concern for the clinician responsible for the patient. Management of infectious complications i n the neutropenic patient is reviewed.